ANI Pharmaceuticals ANIP Free cash flow margin

Free cash flow margin at other companies

Amneal Pharmaceuticals, Inc.AMRX

4.1%-5.8pp

ViatrisVTRS

13.3%+0.9pp

AnaptysBio, Inc.ANAB

1.9%+1.0pp

ALN

Alnylam PharmaceuticalsALNY

16.5%+14.8pp

Eton Pharmaceuticals, Inc.ETON

17.1%—

PVL

Palvella TherapeuticsPVLA

-99.8%-34.2pp

FAQ

What is ANI Pharmaceuticals's free cash flow margin?

ANI Pharmaceuticals (ANIP) reported free cash flow margin of 17.7% in Q2 2026.

How has ANI Pharmaceuticals's free cash flow margin changed year-over-year?

ANI Pharmaceuticals's free cash flow margin increased by 5.3% year-over-year, from 16.8% to 17.7%.

What is the long-term trend for ANI Pharmaceuticals's free cash flow margin?

Over 3 years (2022 to 2025), ANI Pharmaceuticals's free cash flow margin has grown at a 14.2% compound annual growth rate (CAGR), from -13% to 19.4%.

What does free cash flow margin mean?

Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.